DEUTSCHE BANK AG\ - ENZON PHARMACEUTICALS INC ownership

ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 48 filers reported holding ENZON PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ENZON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$04200.0%0.00%
Q4 2015$04200.0%0.00%
Q3 2015$0
-100.0%
420
-99.5%
0.00%
Q2 2015$110,000
+83.3%
92,204
+59.9%
0.00%
Q1 2015$60,00057,669
+13630.7%
0.00%
Q4 2014$04200.0%0.00%
Q3 2014$0
-100.0%
420
-99.4%
0.00%
Q2 2014$74,000
+335.3%
71,994
+308.3%
0.00%
Q1 2014$17,000
+112.5%
17,631
+116.4%
0.00%
Q4 2013$8,000
-91.3%
8,148
-85.3%
0.00%
Q3 2013$92,00055,4360.00%
Other shareholders
ENZON PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Ancora Advisors LLC 50,000$20,0000.00%
MONARCH CAPITAL MANAGEMENT INC/ 10,000$4,0000.00%
ACADIAN ASSET MANAGEMENT LLC 122,287$50,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 254,200$103,0000.00%
TUDOR INVESTMENT CORP ET AL 47,998$19,0000.00%
O'SHAUGHNESSY ASSET MANAGEMENT, LLC 11,181$5,0000.00%
Kistler-Tiffany Companies, LLC 825$00.00%
Tradewinds Capital Management, LLC 200$00.00%
NEXT Financial Group, Inc 60$00.00%
CT Financial Advisors LLC 2,000$810,0000.00%
View complete list of ENZON PHARMACEUTICALS INC shareholders